Latin American consensus on uncomplicated recurrent urinary tract infection—2018
- 7 September 2019
- journal article
- review article
- Published by Springer Nature in International Urogynecology Journal
- Vol. 31 (1) , 35-44
Abstract
An estimated 20–30% of adult women who experience an initial urinary tract infection (UTI) will have recurrent infection. In these patients, prophylaxis may be considered to improve their quality of life and control overuse of antibiotics. Despite this need, there is currently no Latin American consensus on the treatment and prophylaxis of recurrent UTIs. This consensus, signed by a panel of regional and international experts on UTI management, aims to address this need and is the first step toward a Latin American consensus on a number of urogynecological conditions. The panel agrees that antibiotics should be considered the primary treatment option for symptomatic UTI, taking into account local pathogen resistance patterns. Regarding prophylaxis, immunoactive therapy with the bacterial lysate OM-89 received a grade A recommendation and local estrogen in postmenopausal women grade B recommendation. Lower-grade recommendations include behavior modification and D-mannose; probiotics (Lactobacilli), cranberries, and hyaluronic acid (and derivatives) received limited recommendations; their use should be discussed with the patient. Though considered effective and receiving grade A recommendation, antimicrobial prophylaxis should be considered only following prophylaxis with effective non-antimicrobial measures that were not successful and chosen based on the frequency of sexual intercourse and local pathogen resistance patterns.Keywords
This publication has 52 references indexed in Scilit:
- GAG layer replenishment therapy for chronic forms of cystitis with intravesical glycosaminoglycans—A reviewNeurourology and Urodynamics, 2012
- Critical review of current definitions of urinary tract infections and proposal of an EAU/ESIU classification systemInternational Journal of Antimicrobial Agents, 2011
- Waging War against UropathogenicEscherichia coli: Winning Back the Urinary TractInfection and Immunity, 2010
- Immunotherapy for Recurrent Urinary Tract Infections: Effects of an Escherichia coli ExtractCurrent Urology, 2009
- The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA SequencingPLOS Biology, 2008
- CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care settingAmerican Journal of Infection Control, 2008
- Methenamine hippurate for preventing urinary tract infections2002
- Low dose oestrogen prophylaxis for recurrent urinary tract infections in elderly womenBJOG: An International Journal of Obstetrics & Gynaecology, 1998
- A Controlled Trial of Intravaginal Estriol in Postmenopausal Women with Recurrent Urinary Tract InfectionsNew England Journal of Medicine, 1993
- Association of in VitroEscherichia coliAdherence to Vaginal and Buccal Epithelial Cells with Susceptibility of Women to Recurrent Urinary-Tract InfectionsNew England Journal of Medicine, 1981